Susquehanna Fundamental Investments LLC Invests $20.89 Million in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Susquehanna Fundamental Investments LLC bought a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 267,222 shares of the company’s stock, valued at approximately $20,891,000.

Several other hedge funds have also recently added to or reduced their stakes in the business. Coldstream Capital Management Inc. grew its holdings in shares of GE HealthCare Technologies by 4.8% in the 4th quarter. Coldstream Capital Management Inc. now owns 10,021 shares of the company’s stock worth $783,000 after acquiring an additional 457 shares during the last quarter. Hancock Whitney Corp increased its stake in GE HealthCare Technologies by 4.9% in the 4th quarter. Hancock Whitney Corp now owns 22,389 shares of the company’s stock worth $1,750,000 after purchasing an additional 1,047 shares in the last quarter. Voya Investment Management LLC raised its holdings in GE HealthCare Technologies by 124.2% during the 4th quarter. Voya Investment Management LLC now owns 350,737 shares of the company’s stock worth $27,421,000 after buying an additional 194,290 shares during the period. Integrated Wealth Concepts LLC lifted its stake in GE HealthCare Technologies by 0.7% during the fourth quarter. Integrated Wealth Concepts LLC now owns 17,173 shares of the company’s stock valued at $1,343,000 after buying an additional 126 shares in the last quarter. Finally, D1 Capital Partners L.P. boosted its holdings in shares of GE HealthCare Technologies by 22.0% in the fourth quarter. D1 Capital Partners L.P. now owns 3,486,584 shares of the company’s stock worth $272,581,000 after buying an additional 629,270 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Citigroup upped their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and raised their target price for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Piper Sandler dropped their price target on GE HealthCare Technologies from $104.00 to $88.00 and set an “overweight” rating on the stock in a research report on Wednesday. Wells Fargo & Company raised their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Finally, Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their target price for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $96.50.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $68.42 on Friday. The company has a 50 day moving average price of $76.59 and a two-hundred day moving average price of $82.19. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The stock has a market capitalization of $31.33 billion, a PE ratio of 15.80, a price-to-earnings-growth ratio of 3.19 and a beta of 1.14. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. As a group, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.20%. GE HealthCare Technologies’s payout ratio is currently 3.23%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.